These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16195627)

  • 41. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST).
    Krankenberg H; Schlüter M; Steinkamp HJ; Bürgelin K; Scheinert D; Schulte KL; Minar E; Peeters P; Bosiers M; Tepe G; Reimers B; Mahler F; Tübler T; Zeller T
    Circulation; 2007 Jul; 116(3):285-92. PubMed ID: 17592075
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Durability of Treatment Effect Using a Drug-Coated Balloon for Femoropopliteal Lesions: 24-Month Results of IN.PACT SFA.
    Laird JR; Schneider PA; Tepe G; Brodmann M; Zeller T; Metzger C; Krishnan P; Scheinert D; Micari A; Cohen DJ; Wang H; Hasenbank MS; Jaff MR;
    J Am Coll Cardiol; 2015 Dec; 66(21):2329-2338. PubMed ID: 26476467
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Percutaneous transluminal angioplasty with or without stenting for femoropopliteal occlusions? A randomized controlled study.
    Zdanowski Z; Albrechtsson U; Lundin A; Jonung T; Ribbe E; Thörne J; Norgren L
    Int Angiol; 1999 Dec; 18(4):251-5. PubMed ID: 10811511
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of the kallikrein-kinin system, metalloproteinases, and their tissue inhibitors in the in-stent restenosis after peripheral percutaneous angioplasty.
    Ribeiro MS; Dellalibera-Joviliano R; Becari C; Teixeira FR; Araujo PV; Piccinato CE; Campos CP; Evora PR; Joviliano EE
    Ann Vasc Surg; 2014 May; 28(4):1005-15. PubMed ID: 24440188
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multicenter randomized trial of 3-month cilostazol use in addition to dual antiplatelet therapy after biolimus-eluting stent implantation for long or multivessel coronary artery disease.
    Youn YJ; Lee JW; Ahn SG; Lee SH; Choi H; Yu CW; Hong YJ; Kwon HM; Hong MK; Jang Y; Yoon J
    Am Heart J; 2014 Feb; 167(2):241-248.e1. PubMed ID: 24439986
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stent placement versus balloon angioplasty for the treatment of obstructive lesions of the popliteal artery: a prospective, multicenter, randomized trial.
    Rastan A; Krankenberg H; Baumgartner I; Blessing E; Müller-Hülsbeck S; Pilger E; Scheinert D; Lammer J; Gißler M; Noory E; Neumann FJ; Zeller T
    Circulation; 2013 Jun; 127(25):2535-41. PubMed ID: 23694965
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Angiographic Dissection Patterns and Patency Outcomes After Balloon Angioplasty for Superficial Femoral Artery Disease.
    Fujihara M; Takahara M; Sasaki S; Nanto K; Utsunomiya M; Iida O; Yokoi Y
    J Endovasc Ther; 2017 Jun; 24(3):367-375. PubMed ID: 28351208
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vascular brachytherapy with 192Ir after femoropopliteal stent implantation in high-risk patients: twelve-month follow-up results from the Vienna-5 trial.
    Wolfram RM; Budinsky AC; Pokrajac B; Pötter R; Minar E
    Radiology; 2005 Jul; 236(1):343-51. PubMed ID: 15987985
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Effect of Cilostazol on the Angiographic Outcome of Drug-Eluting Coronary Stents Angiographic Analysis of the CILON-T (Influence of CILostazol-Based Triple Antiplatelet Therapy ON Ischemi Complication after Drug-Eluting StenT Implantation) Trial.
    Suh JW; Lee SP; Park K; Kang HJ; Koo BK; Cho YS; Youn TJ; Chae IH; Choi DJ; Rha SW; Bae JH; Kwon TG; Bae JW; Cho MC; Kim HS
    Int Heart J; 2017 Dec; 58(6):853-860. PubMed ID: 29118299
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transluminal stenting for femoropopliteal occlusive disease: analysis of restenosis by serial arteriography.
    Bui TD; Gordon IL; Nguyen T; Fujitani RM; Wilson SE; Conroy RC
    Ann Vasc Surg; 2006 Mar; 20(2):200-8. PubMed ID: 16555031
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of cilostazol on angiographic restenosis after balloon angioplasty for infrapopliteal artery disease in patients with critical limb ischemia.
    Soga Y; Iida O; Kawasaki D; Hirano K; Yamaoka T; Suzuki K
    Eur J Vasc Endovasc Surg; 2012 Dec; 44(6):577-81. PubMed ID: 23107298
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intraoperative iliac artery stents: combination with infra-inguinal revascularization procedures.
    Demasi RJ; Snyder SO; Wheeler JR; Gregory RT; Gayle RG; Parent FN; Gandhi RH
    Am Surg; 1994 Nov; 60(11):854-9. PubMed ID: 7978681
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease).
    Lammer J; Zeller T; Hausegger KA; Schaefer PJ; Gschwendtner M; Mueller-Huelsbeck S; Rand T; Funovics M; Wolf F; Rastan A; Gschwandtner M; Puchner S; Ristl R; Schoder M
    J Am Coll Cardiol; 2013 Oct; 62(15):1320-7. PubMed ID: 23831445
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial.
    Tepe G; Laird J; Schneider P; Brodmann M; Krishnan P; Micari A; Metzger C; Scheinert D; Zeller T; Cohen DJ; Snead DB; Alexander B; Landini M; Jaff MR;
    Circulation; 2015 Feb; 131(5):495-502. PubMed ID: 25472980
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Debulking and stenting versus debulking only of coronary artery disease in patients treated with cilostazol (final results of ESPRIT).
    Tsuchikane E; Kobayashi T; Kobayashi T; Takeda Y; Otsuji S; Sakurai M; Awata N
    Am J Cardiol; 2002 Sep; 90(6):573-8. PubMed ID: 12231079
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of cilostazol on late lumen loss and repeat revascularization after Palmaz-Schatz coronary stent implantation.
    Kozuma K; Hara K; Yamasaki M; Morino Y; Ayabe S; Kuroda Y; Tanabe K; Ikari Y; Tamura T
    Am Heart J; 2001 Jan; 141(1):124-30. PubMed ID: 11136497
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical outcomes of balloon angioplasty alone versus nitinol stent implantation in patients with small femoropopliteal artery disease: Observations from the Retrospective Multicenter Analysis for Femoropopliteal Stenting (REAL-FP).
    Kamioka N; Soga Y; Kuramitsu S; Iida O; Hirano K; Suzuki K; Kawasaki D; Yamaoka T; Suematsu N; Shintani Y; Miyashita Y; Takahashi H; Tsuchiya T; Shinozaki N; Okazaki S; Ando K
    Catheter Cardiovasc Interv; 2017 Nov; 90(5):790-797. PubMed ID: 28722294
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease.
    Mehrotra S; Paramasivam G; Mishra S
    Curr Cardiol Rep; 2017 Feb; 19(2):10. PubMed ID: 28185166
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stent placement vs. balloon angioplasty for popliteal artery treatment: two-year results of a prospective, multicenter, randomized trial.
    Rastan A; Krankenberg H; Baumgartner I; Blessing E; Müller-Hülsbeck S; Pilger E; Scheinert D; Lammer J; Beschorner U; Noory E; Neumann FJ; Zeller T
    J Endovasc Ther; 2015 Feb; 22(1):22-7. PubMed ID: 25775675
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of cilostazol on angiographic restenosis after coronary stent placement.
    Park SW; Lee CW; Kim HS; Lee NH; Nah DY; Hong MK; Kim JJ; Park SJ
    Am J Cardiol; 2000 Sep; 86(5):499-503. PubMed ID: 11009265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.